Science for Women's Health Innovation
Friday, January 30, 2026 - 8:30am to 6:00pmThe Science for Women's Health Innovation symposium hosted by Columbia Engineering will bring together over 140 industry leaders and Columbia researchers and collaborators to drive future generations of innovation in women's health.
Panels will cover topics such as gynecologic health, preterm/pregnancy health, pelvic floor, commercialization and regulatory path, and education and workforce. Our three confirmed keynote speakers include:
- Silvia Blemker | Professor of Biomedical Engineering | University of Virginia
- Sandra Brown | Dean and Professor | College of Nursing, Southern University
- Steve Levine | Sr. Director of Virtual Human Modeling | Dassault Systèmes
Ignite Connect 2026
Thursday, January 29, 2026 - 12:00pm to 2:00pmIgnite Connect 2026 is the third annual virtual partnering forum highlighting a curated portfolio of Cornell University originated technologies and venture teams that have progressed beyond concept validation and into investable projects.
Presenters featured in Ignite Connect are recipients of the Ignite or EI Catalyst Fund, competitive gap-funding programs designed to de-risk Cornell early technologies, validate market hypotheses, and advance projects past technical or commercial inflection points. These projects represent opportunities that are actively preparing for pre-seed investment, strategic partnerships, licensing, or sponsored development.
Weill Cornell innovators and startup founders will be presenting their technologies. Want to hear about their innovations and translational investment? Register here.
CTL@WCM Office Hours with Louise Sarup
Tuesday, January 27, 2026 - 2:00pm to 4:00pmCenter for Technology Licensing (CTL) at Weill Cornell Medicine Office Hours are open to all who wish to gain more information about the advancement of their patent filings and to discuss their technology venture project with a one-on-one meeting with a Weill Cornell business development and licensing professional.
The January office hours will be hosted by Louise Sarup, Ph.D., associate director, business development and licensing. Louise manages a portfolio of medical technologies focusing on imaging, platform technologies and algorithms. She is a seasoned professional with years of experience in licensing and commercialization and is eager to answer your questions and provide valuable insights.
Prior to joining the Center for Technology Licensing, Louise was based in Singapore where she was head of business development and licensing for D3 (now EDDC), a drug discovery and development group based at A*STAR. Some of her previous roles include corporate development manager at S*BIO Pte Ltd. (Singapore), an oncology-focused biotech, vice president of business development at Paramount Biosciences (London), where she was responsible for in-licensing drug development assets and director (licensing) at Cytiva, a global life science company. Louise has also worked for leading life science and health care communication agencies and UCL Business, the commercialization company of University College London.
Register here for your 30-minute private session.
Telling Your Scientific Story for Commercialization Impact
Thursday, January 22, 2026 - 12:00pm to 1:00pmJoin us on January 22 for "Telling Your Scientific Story for Commercialization Impact," a new Lab to Impact workshop designed to help researchers and innovators at Cornell University communicate their innovations beyond the lab.
Dr. Julia Felice, a Cornell University alumna, scientist, communicator, and founder of Felice Information Design, will guide participants through how narrative can strengthen understanding, build trust, and accelerate the path from discovery to real-world impact.
In this session, attendees will learn how to adapt their scientific story for diverse audiences, develop a concise “hook” that conveys value to non-technical decision makers, and leave with a practical checklist to support future communication efforts. Participants will also have the opportunity to sign up for follow-up office hours with Dr. Felice for individualized feedback.
If you’re working on a technology with commercial potential, this workshop will help you bridge the communication chasm and position your innovation for stronger partnerships, funding, and traction.
Register here.
Filing Deadlines, Tax, and Regulatory Obligations
Friday, January 16, 2026 - 12:00pm to 1:00pmStay ahead of the paperwork that too often slips through the cracks. Join us for an informative session with Nate Cook, Founder of Klausner Cook PLLC, a Corporate, Real Estate, and Intellectual Property Law Practice, and Tom D’Alessandro, Tax Department Head at Sciarabba Walker & Co., LLP, who will break down the essential filing deadlines, tax requirements and regulatory obligations every startup should have on their radar.
Whether you're unsure about what you might be missing or simply want to confirm you're on the right track, this session clarifies financial and legal responsibilities you may not know about.
Perfect for founders looking to stay compliant, RSVP today!
Biomedical Innovation Challenge Info Session
Wednesday, January 14, 2026 - 12:30pm to 1:00pmYou are invited to join us for a virtual information session on the upcoming Biomedical Innovation Challenge, Weill Cornell Medicine’s venerable faculty-focused accelerator for translational innovation, which begins later this month.
During this session, BioVenture eLab Director Loren Busby will provide an overview of the program’s structure, expectations, and selection criteria, and will answer questions from prospective applicants.
The Biomedical Innovation Challenge is a selective, three-month, hands-on accelerator that supports faculty-led teams in developing rigorous development and commercialization strategies for their innovations. Participants work closely with seasoned industry mentors—serial entrepreneurs, investors, and corporate leaders—to refine their scientific, regulatory, and business plans and prepare for a pitch competition judged by venture capital and industry experts. The program is open to Weill Cornell Medicine scientists and clinician innovators.
Accelerating BioVenture Innovation Final Pitch Replay
Monday, January 12, 2026 - 6:00pm to 7:15pmIf you were unable to attend the live event on December 9, we invite you to join us for an exclusive Zoom replay of the 2025 Accelerating BioVenture Innovation (ABI ) Final Pitch Competition.
Weekly Office Hours on Industry Funded and Sponsored Research
Friday, January 9, 2026 - 11:00am to 1:00pmDo you have a project in need of funding? Are you interested in learning about engaging with industry partners?
James Bellush, Manager of Scientific Scouting, will be hosting weekly virtual office hours, every Friday from 11 a.m. to 1 p.m. to help Weill Cornell investigators support their ongoing translational research projects through industry sponsored research collaborations and grants.
Please use the link here to schedule your private meeting with James. Questions? Email james.bellush@cornell.edu.
Life Sciences Data Sharing Deals in an Era of "Data is Gold"
Wednesday, January 7, 2026 - 12:00pm to 1:15pmAs data-driven innovation accelerates, healthcare stakeholders still struggle with a central question: How do we quantify the value of the data we hold? Even with unprecedented volumes of clinical and operational data, valuation methods remain fragmented and inconsistent. Providers, entrepreneurs and investors often approach data with very different priorities and expectations. Persistent challenges include gaps between perceived and realizable data value, difficulty comparing heterogeneous datasets, and increasing legal and regulatory constraints.
This session will examine how hospitals, digital health innovators, medtech companies and investors are defining and benchmarking data value in real-world transactions. The panel will also explore recommendations for strong data-sharing agreements and how expectations for rigorous, auditable valuation models are evolving.
RSVP here.
Panelists include:
- Roger Cohen, Partner, Goodwin Procter (Moderator)
- Greg Banker, Partner, Vensana Capital
- Chris David, Founder & Managing Partner, HealthValue Group
- Natasha Hunerlach, Partner, EY/Parthenon
- Stefan Vilsmeier, Founder, President & CEO, Brainlab
*This program is being organized by BioVenture eLab of Weill Cornell Medicine Enterprise Innovation with Wendy Diller, founder of LifeScInnovation and author of “Data is the New Gold: Quantifying Its Value To Medtech Presents Challenges,” published in the October 2025 issue of Medtech Strategist.
CTL at Weill Cornell Medicine Office Hours with Eric Bryant
Tuesday, December 16, 2025 - 2:00pm to 4:00pmCenter for Technology Licensing (CTL) at Weill Cornell Medicine Office Hours with Eric Bryant are held every other month and open to all who wish to get answers to their intellectual property questions and gain more information about the advancement of their IP filings with a one-on-one meeting.
Eric holds a Master of Science in Biomedical Engineering from New York University, a Juris Doctor from New York Law School, and is a registered patent attorney. He works with the Weill Cornell office to execute on intellectual property strategy, review submitted invention disclosures, and manage domestic and foreign patent filings and patent prosecution.
Eric’s expertise encompasses a variety of technologies including, but not limited to, diagnostics tools and methods, pharmaceuticals, controlled release therapeutic devices, respiratory devices, surgical tools, biological technologies and nanotechnology.
To reserve your private, 30-minute Zoom session with Eric, click here.
